Ventricular oversensing: A study of 101 patients implanted with dual chamber defibrillators and two different lead systems

PACE - Pacing and Clinical Electrophysiology

Volumn 26, Issue 1 I, 2003, Pages 65-70

  Weretka, Slawomir ^a   Michaelsen, Jochen ^a   Becker, Ruediger ^a   Karle, Christoph A ^a   Voss, Frederik ^a   Hilbel, Thomas ^a   Osswald, Brigitte R ^a   Bahner, Malte L ^a   Senges, Julia C ^a   Kuebler, Wolfgang ^a   Schoels, Wolfgang ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Dual chamber; Implantable cardioverter defibrillator; Leads; Oversensing

Indexed keywords

ADULT; AGED; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; HEART VENTRICLE FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; P WAVE; PACEMAKER ELECTRODE; RELIABILITY; T WAVE;

EID: 0037245991     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.00152.x     Document Type: Article

References (27)

1. Kopp DE, Burke MC, Lin AC, et al. Oversensing in dual chamber implantable cardioverter defibrillators. (abstract) PACE 2000; 23:591.
2. Deshmukh P, Anderson K. Myopotential sensing by a dual chamber implantable cardioverter defibrillator: Two case reports. J Cardiovasc Electrophysiol 1998; 9:767-772.
3. Glotzer TV, Radoslovich GA, Neglia J, et al. Variability of atrial sensing during exercise in a patient with a dual chamber ICD caused inappropriate ICD discharges. PACE 1999; 22:1838-1841.
4. Weretka S, Becket R, Hilbel T, et al. Far-field R wave oversensing in a dual chamber arrhythmia management device: Predisposing factors and practical implications. PACE 2001; 24:1240-1246.
5. Gunderson BD, Pratt T, Ben Johnson W, et al. Ventricular oversensing in ICD patients: True bipolar versus integrated bipolar sensing. (abstract) PACE 2001; 24:560.
6. Degeratu FT, Khalighi K, Peters RW, et al. Sensing lead failure in implantable cardioverter defibrillators: A comparison of two commonly used leads. J Cardiovasc Electrophysiol 2000; 11:21-24.
7. Goldberger JJ, Horvath G, Donovan D, et al. Detection of ventricular fibrillation by transvenous defibrillating leads: Integrated versus dedicated bipolar sensing. J Cardiovasc Electrophysiol 1998; 9:677-688.
8. Gottlieb CD, Schwartzman DS, Callans DJ, et al. Effects of high and low shock energies on sinus electrograms recorded via integrated and true bipolar nonthoracotomy lead systems. J Cardiovasc Electrophysiol 1996; 7:189-196.
9. Jung W, Manz M, Moosdorf R, et al. Failure of an implantable cardioverter-defibrillator to redetect ventricular fibrillation in patients with a nonthoracotomy lead system. Circulation 1992; 86:1217-1222.
10. Natale A, Sra J, Axtell K, et al. Undetected ventricular fibrillation in transvenous implantable cardioverter defibrillators. Prospective comparison of different lead system-device combinations. Circulation 1996; 93:91-98.
11. Isbruch FM, Block M, Boecker D, et al. Improved sensing signals after endocardial defibrillation with a redesigned integrated sense, pace, defibrillation lead. PACE 1996; 19:1211-1218.
12. Cooklin M, Tummala RV, Peters RW, et al. Comparison of bipolar and integrated sensing for redetection of ventricular fibrillation. Am Heart J 1999; 138:133-136.
13. Singer I, de Borde R, VeltriEP, et al. The automatic implantable cardioverter defibrillator: T wave sensing in the newest generation. PACE 1988; 11:1584-1591.
14. Grimm W, Flores BF, Marchlinski FE, et al. Electrocardiographically documented unnecessary spontaneous shocks in 241 patients with implantable cardioverter defibrillator. PACE 1992; 15:1667-1673.
15. Kelly PA, Mann DE, Damle RS, et al. Oversensing during ventricular pacing in patients with third-generation of implantable cardioverter defibrillator. J Am Coll Cardiol 1994; 23:1531-1534.
16. Mann DE, Damle RS, Kelly P, et al. Comparison of oversensing during bradycardia pacing in two types of implantable cardioverter defibrillator systems. Am Heart J 1998; 136:658-663.
17. vanGelder BM, Bracke FA, El Gamal MI. P wave oversensing in a unipolar VVI pacemaker. PACE 1995; 18:370-373.
18. Paraskevaidis S, Mochlas S, Hadjimiltiadis S, et al. Intermittent P wave sensing in a patient with DDD pacemaker. PACE 1999; 22:689-690.
19. Curwin JH, Roelke M, Ruskin JN. Inhibition of bradycardia pacing caused by far-field atrial sensing in a third-generation cardioverter defibrillator with an automatic gain feature. PACE 1996; 19:124-126.
20. Mann DE, Otto L, Kelly PA, et al. Effect of sensing system on the incidence of myopotential oversensing during bradycardia pacing in implantable cardioverter-defibrillators. Am J Cardiol 2000; 85:1380-1382.
21. Sweeney MO, Ellison KE, Shea JB, et al. Provoked and spontaneous high frequency, low-amplitude, respirophasic noise transients in patients with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 2001; 12:402-410.
22. Barold SS, Falkoff MD, Ong LS, et al. Oversensing by single chamber pacemakers: Mechanisms, diagnosis and treatment. Cardiol Clin 1985; 3:565-585.
23. Xiao HB, Brecker SJ, Gibson DG. Relative effects of left ventricular mass and conduction disturbance on activation in patients with pathological left ventricular hypertrophy. Br Heart J 1994; 71:548-553.
24. Xiao HB, Roy C, Fujimoto S, et al. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int J Cardiol 1996; 53:163-170.
25. Zaidi M, Robert A, Fesler R, et al. Dispersion of ventricular repolarization in dilated cardiomyopathy. Eur Heart J 1997; 18:1129-1134.
26. Boriani G, Biffi M, Frabetti L, et al. Cardioverter-defibrillator oversensing due to double counting of ventricular tachycardia electrograms. Int J Cardiol 1998; 66:91-95.
27. Peters W, Hopp H, Bauer WR, et al. An unusual series of complications in therapy with implantable cardioverter-defibrillator. Z Kardiol 1995; 84:296-300.